Validation of 24-Hour Flucytosine MIC Determination by Comparison with 48-Hour Determination by the Clinical and Laboratory Standards Institute M27-A3 Broth Microdilution Reference MethodLOCKHART, Shawn R; BOLDEN, Carol B; IQBAL, Naureen et al.Journal of clinical microbiology (Print). 2011, Vol 49, Num 12, pp 4322-4325, issn 0095-1137, 4 p.Article

La flucytosine en 1984 = Flucytosine in 1984BENNETT, J. E.Médecine et maladies infectieuses. 1985, Vol 15, Num 6, pp 332-336, issn 0399-077XArticle

TREATMENT OF SEVERE CHROMOBLASTOMYCOSIS WITH ITRACONAZOLE AND 5-FLUCYTOSINE ASSOCIATIONANTONELLO, Vicente Sperb; APPEL DA SILVA, Marcelo Campos; CAMBRUZZI, Eduardo et al.Revista do Instituto de Medicina Tropical de São Paulo. 2010, Vol 52, Num 6, pp 329-331, issn 0036-4665, 3 p.Article

High performance liquid chromatographic assay of 5-fluorouracil and 5-fluorocytosineBIONDI, L; NAIRN, J. G.Journal of liquid chromatography. 1985, Vol 8, Num 10, pp 1881-1892, issn 0148-3919Article

TREATMENT OF EXPERIMENTAL CRYPTOCOCCAL MENINGITIS WITH AMPHOTERICIN B, 5-FLUOROCYTOSINE, AND KETOCONAZOLEPERFECT JR; DURACK DT.1982; JOURNAL OF INFECTIOUS DISEASES; ISSN 0022-1899; USA; DA. 1982; VOL. 146; NO 3; PP. 429-435; BIBL. 26 REF.Article

Genetic prerequisites for additive or synergistic actions of 5-fluorocytosine and fluconazole in baker's yeastPALUSZYNSKI, John P; KLASSEN, Roland; MEINHARDT, Friedhelm et al.Microbiology (Reading). 2008, Vol 154, pp 3154-3164, issn 1350-0872, 11 p., 10Article

Stability of flucytosine 50 mg/ml in extemporaneous oral liquid formulationsVANDENBUSSCHE, Heather L; JOHNSON, Cary E; JIN YUN et al.American journal of health-system pharmacy. 2002, Vol 59, Num 19, pp 1853-1855, issn 1079-2082Article

Life-threatening 5-fluorouracil-like cardiac toxicity after treatment with 5-fluorocytosineISETTA, C; GARAFFO, R; BASTIAN, G et al.Clinical pharmacology and therapeutics. 2000, Vol 67, Num 3, pp 323-325, issn 0009-9236Article

Population pharmacokinetics of flucytosine : Comparison and validation of three models using STS, NPEM, and NONMEMVERMES, Andras; MATHOT, Ron A. A; VAN DER SIJS, I. Heleen et al.Therapeutic drug monitoring. 2000, Vol 22, Num 6, pp 676-687, issn 0163-4356Article

Flucytosine monotherapy for cryptococcosisHOSPENTHAL, D. R; BENNETT, J. E.Clinical infectious diseases. 1998, Vol 27, Num 2, pp 260-264, issn 1058-4838Article

Flucytosine resistance is restricted to a single genetic clade of Candida albicansPUJOL, Claude; PFALLER, Michael A; SOLL, David R et al.Antimicrobial agents and chemotherapy. 2004, Vol 48, Num 1, pp 262-266, issn 0066-4804, 5 p.Article

Treatment of vaginitis caused by Candida glabrata: Use of topical boric acid and flucytosineSOBEL, Jack D; CHAIM, Walter; NAGAPPAN, Viji et al.American journal of obstetrics and gynecology. 2003, Vol 189, Num 5, pp 1297-1300, issn 0002-9378, 4 p.Article

L'ASSOCIATION KETOCONAZOLE-5 FLUOROCYTOSINE DANS LE TRAITEMENT DE L'ASPERGILLOSE PULMONAIRE. A PROPOS DE DEUX CASKOENIG H; CHARBONNEAU J; REMPP M et al.1982; BULL. SOC. FR. MYCOL. MED.; ISSN 0373-8744; FRA; DA. 1982; VOL. 11; NO 1; PP. 127-131; ABS. ENG; BIBL. 5 REF.Article

NEW ANTIFUNGAL DRUGHOLT RJ.1975; DRUGS; SWITZ.; DA. 1975; VOL. 9; NO 6; PP. 401-405; BIBL. 14REF.Article

PHENOTYPES DE RESISTANCE A LA 5-FLUOROCYTOSINE CHEZ CRYPTOCOCCUS NEOFORMANSDROUHET E; ALAYSE AM; IMPROVISI L et al.1976; BULL. SOC. FR. MYCOL. MED.; FR.; DA. 1976; VOL. 5; NO 1; PP. 17-20; ABS. ANGL.; BIBL. 8 REF.Article

5-FLUOROCYTOSINE IN THE TREATMENT OF MYCOTIC INFECTIONSVANDEVELDE AG; MAUCERI AA; JOHNSON JE III et al.1972; ANN. INTERN. MED.; U.S.A.; DA. 1972; VOL. 77; NO 1; PP. 43-51; BIBL. 28 REF.Serial Issue

Determination of allopurinol and flucytosine in tablets by differential UV spectroscopySHOUKRALLAH, I; SAKLA, A; WINTERSTEIGER, R et al.Analytical letters. 1990, Vol 23, Num 5, pp 843-861, issn 0003-2719, 19 p.Article

Simplified bioassay method for measurement of flucytosine or ketoconazoleBODET, C. A. III; JORGENSEN, J. H; DRUTZ, D. J et al.Journal of clinical microbiology (Print). 1985, Vol 22, Num 2, pp 157-160, issn 0095-1137Article

Decreased activity of UMP pyrophosphorylase associated with resistance to 5-fluorocytosine in Candida albicansWHELAN, W. L; KERRIDGE, D.Antimicrobial agents and chemotherapy. 1984, Vol 26, Num 4, pp 570-574, issn 0066-4804Article

Expression profiling of the response of Saccharomyces cerevisiae to 5-fluorocytosine using a DNA microarrayLIANG ZHANG; YAN ZHANG; YIMING ZHOU et al.International journal of antimicrobial agents. 2002, Vol 20, Num 6, pp 444-450, issn 0924-8579, 7 p.Article

Falsely elevated serum creatinine levels secondary to the presence of 5-fluorocytosineMITCHELL, R. T; MARSHALL, L. H; LEFKOWITZ, L. B. JR et al.American journal of clinical pathology. 1985, Vol 84, Num 2, pp 251-253, issn 0002-9173Article

Modification of the fluorescein diacetate assay for screening of antifungal agents against Candida albicans : Comparison with the NCCLS methodsBROUWER, Nynke; KOHEN, James; JAMIE, Joanne et al.Journal of microbiological methods. 2006, Vol 66, Num 2, pp 234-241, issn 0167-7012, 8 p.Article

An in vitro study on the Active conversion of Flucytosine to fluorouracil by microorganisms in the human intestinal microfloraVERMES, Andras; KUIJPER, Ed J; GUCHELAAR, Henk-Jan et al.Chemotherapy (Basel). 2003, Vol 49, Num 1-2, pp 17-23, issn 0009-3157, 7 p.Article

RAPID FLUORIMETRIC DETERMINATION OF 5-FLUOROCYTOSINE IN SERUM.RICHARDSON RA.1975; CLIN. CHIM. ACTA; PAYS-BAS; DA. 1975; VOL. 63; NO 2; PP. 109-114; BIBL. 12 REF.Article

SENSIBILITE ET RESISTANCE DES LEVURES PATHOGENES AUX 5-FLUOROPYRIMIDINES. I. RELATION ENTRE LES PHENOTYPES DE RESISTANCE A LA 5-FLUOROCYTOSINE, LE SEROTYPE DE CANDIDA ALBICANS ET L'ECOLOGIE DE DIFFERENTES ESPECES DE CANDIDA D'ORIGINE HUMAINE.DROUHET E; MERCIER SOUCY L; MONTPLAISIR S et al.1975; ANN. MICROBIOL.; FR.; DA. 1975; VOL. 126; NO 1; PP. 25-39; ABS. ANGL.; BIBL. 2 P.Article